Buscar
Mostrando ítems 1-10 de 19
Chronic chagasic cardiomiopathy: role of CD4 cells in the anti heart autoreactivity
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 2019)
TNF-α and TNFR in Chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy
(Springer Verlag (Germany), 2018)
Chronic chagasic cardiomiopathy: role of CD4 cells in the anti heart autoreactivity
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 1990)
The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 2018)
Manejo de cardiomiopatia chagasica : revisión sistemática (1996-2010)
(Universidad del RosarioInstituto de Ciencias de la Salud. CESFacultad de medicina, 2010)
Chagasic cardiomyopathy is the most important and severe manifestation of chronic disease, patients may present heart failure, arrhythmias, and heart block, thromboembolism and sudden death. The diagnosis is delayed, because ...
TNF-α and TNFR in Chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy
(Springer Verlag (Germany), 2011)
Avaliação de biomarcadores para a cardiomiopatia chagásica crônica
(Universidade Federal do Rio Grande do NorteBrasilUFRNPROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA PARASITÁRIA, 2021-02-26)
Chronic chagasic cardiomiopathy is observed in 17-50% of patients, contributing to
morbidity and mortality of Chagas disease. There are no biomarkers of clinical
evolution described for Chagas disease, requiring high-cost ...
IMPLICATIONS OF SUDDEN DEATH IN CHAGAS DISEASE
(Universidade Federal de Goiás, 2007)